SCHEMBL2656267

SCHEMBL2656267

CC(CC(=O)Nc1nccs1)Oc1cccc(C(=O)O)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 7/20 0.56
▸ RAB9A P51151 7/20 0.56
▸ SMN1; SMN2 Q16637 5/20 0.56
▸ HPGD P15428 2/20 0.56
▸ TP53 P04637 2/20 0.54
▸ THRB P10828 1/20 0.54
▸ ALDH1A1 P00352 3/20 0.51
▸ LMNA P02545 2/20 0.51
▸ MEN1 O00255 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ ADORA2A P29274 1/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.47
▸ MAPT P10636 2/20 0.47
▸ NFKB1 P19838 1/20 0.47
▸ NFKB2 Q00653 1/20 0.47
▸ RELA Q04206 1/20 0.47
▸ GCK P35557 4/20 0.46
▸ PKM P14618 2/20 0.46
▸ CDK5 Q00535 1/20 0.46
▸ CDK5R1 Q15078 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2656141 0.88 ADORA2A (0.54) NPC1RAB9ASMN1; SMN2HPGDTP53
SCHEMBL2656757 0.87 NPC1 (0.52) NPC1RAB9ASMN1; SMN2HPGDTP53
SCHEMBL2656269 0.80 HPGD (0.59) NPC1RAB9ASMN1; SMN2HPGDTP53
SCHEMBL12858465 0.79 GCK (0.74) GCK
SCHEMBL13891583 0.79 GCK (0.74) GCK
SCHEMBL27652020 0.77 RAB9A (0.74) NPC1RAB9ASMN1; SMN2HPGDTP53
SCHEMBL2656595 0.76 NPC1 (0.56) NPC1RAB9ASMN1; SMN2HPGDTP53
Hydrochloric Acid SCHEMBL7381662 0.74 MEN1 (0.54) NPC1RAB9ASMN1; SMN2HPGDTP53
SCHEMBL12238632 0.73 ADORA2A (0.71) NPC1RAB9ASMN1; SMN2HPGDTP53
Isophthalic Acid SCHEMBL27829644 0.72 NPC1 (0.55) NPC1RAB9ASMN1; SMN2HPGDTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2125735-A2 2,2,2-TRI-SUBSTITUTED ACETAMIDE DERIVATIVES AS GLUCOKINASE ACTIVATORS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION Advinus Therapeutics Private Limited (IN) 2009-12-02 — — EP disclosed
WO-2008104994-A2 2,2,2-TRI-SUBSTITUTED ACETAMIDE DERIVATIVES AS GLUCOKINASE ACTIVATORS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION ADVINUS THERAPEUTICS PRIVATE LIMITED (IN) 2008-09-04 — — WO disclosed
Send feedback